Munafa Stock Market Course + Intraday & FNO calls 
Biomarin Pharmaceutical (BMRN) Technical (Analysis) Reports Biomarin Pharmaceutical ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Biomarin Pharmaceutical (BMRN)
Technical Analysis Report for NASDAQ stock BMRN Biomarin Pharmaceutical. Dated: 14 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock BMRN Biomarin Pharmaceutical then click here. or read Experts views on Biomarin Pharmaceutical or Forecast & share price targets of Biomarin Pharmaceutical
Biomarin Pharmaceutical Opened at 53.78 and Closed at: 53.24, which is -0.58% of previous session's close. It moved within a range of 52.64 and 54.09
The session was a Bearish session with an average volume of 1158900, which is -76.01% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 52.22 and resistance for tomorrow is 53.67
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 52.56, 51.87 resistance for tomorrow's hourly charts is 54.01, 54.77
10 Day SMA for Biomarin Pharmaceutical (BMRN) is 53.84 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Biomarin Pharmaceutical (BMRN) is 53.92 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Biomarin Pharmaceutical (BMRN) is 55.51 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 57.26 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Biomarin Pharmaceutical is 56.15 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Biomarin Pharmaceutical is at 53.92 and 200 DMA is at 56.15, while 50 DMA and 100 DMA are at 55.51 and 57.26 respectively
Biomarin Pharmaceutical (BMRN) moving average of 20 SMA is at 53.92 and 20 EMA is at 54.04
| Date | Closing Price | 20 SMA | 20 EMA |
| 14 Thu May | 53.24 | 53.92 | 54.04 |
| 13 Wed May | 53.55 | 53.99 | 54.12 |
| 12 Tue May | 52.88 | 54.02 | 54.18 |
| 11 Mon May | 52.58 | 54.14 | 54.32 |
| 08 Fri May | 54.06 | 54.28 | 54.5 |
| 07 Thu May | 54.12 | 54.33 | 54.55 |
Biomarin Pharmaceutical (BMRN) moving average of 50 SMA is at 55.51 and 50 EMA is at 55.22
| Date | Closing Price | 50 SMA | 50 EMA |
| 14 Thu May | 53.24 | 55.51 | 55.22 |
| 13 Wed May | 53.55 | 55.65 | 55.3 |
| 12 Tue May | 52.88 | 55.75 | 55.37 |
| 11 Mon May | 52.58 | 55.89 | 55.47 |
| 08 Fri May | 54.06 | 56.07 | 55.59 |
| 07 Thu May | 54.12 | 56.21 | 55.65 |
Biomarin Pharmaceutical (BMRN) moving average of 100 SMA is at 57.26 and 100 EMA is at 56.04
| Date | Closing Price | 100 SMA | 100 EMA |
| 14 Thu May | 53.24 | 57.26 | 56.04 |
| 13 Wed May | 53.55 | 57.34 | 56.1 |
| 12 Tue May | 52.88 | 57.32 | 56.15 |
| 11 Mon May | 52.58 | 57.31 | 56.22 |
| 08 Fri May | 54.06 | 57.31 | 56.29 |
| 07 Thu May | 54.12 | 57.29 | 56.34 |
Biomarin Pharmaceutical (BMRN) moving average of 200 SMA is at 56.15 and 200 EMA is at 57.13
| Date | Closing Price | 200 SMA | 200 EMA |
| 14 Thu May | 53.24 | 56.15 | 57.13 |
| 13 Wed May | 53.55 | 56.18 | 57.17 |
| 12 Tue May | 52.88 | 56.2 | 57.21 |
| 11 Mon May | 52.58 | 56.23 | 57.25 |
| 08 Fri May | 54.06 | 56.26 | 57.3 |
| 07 Thu May | 54.12 | 56.29 | 57.33 |
Veracyte Inc has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Veracyte Inc, about 19.28% more returns!
Biomarin Pharmaceutical has performed better than Synergetics Usa in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Riot Blockchain has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Riot Blockchain, about 38.94% more returns!
Replimune Group has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Replimune Group, about 141.82% more returns!
Pulse Biosciences has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Pulse Biosciences, about 17.19% more returns!
Biomarin Pharmaceutical has performed better than Phio Pharmaceuticals in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Pavmed Inc in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Mimedx Group has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Mimedx Group, about 12.56% more returns!
Kura Oncology has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Kura Oncology, about 2.58% more returns!
Abeona Therapeutics has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Abeona Therapeutics, about 4.99% more returns!
Agios Pharmaceuticals has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Agios Pharmaceuticals, about 9.2% more returns!
Biomarin Pharmaceutical has performed better than Caredx Inc in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Cocrystal Pharma in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Editas Medicine in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Fennec Pharmaceuticals has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 40.29% more returns!
Biomarin Pharmaceutical has performed better than Heron Therapeutics in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Immuron has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Immuron, about 15.49% more returns!
Biomarin Pharmaceutical Technical analysis of indicators
Price action analysis of Biomarin Pharmaceutical (BMRN) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term and the sell signal is strong.
Biomarin Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 53.8 and Biomarin Pharmaceutical BMRN stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical BMRN stock. Volume based technical analysis of Biomarin Pharmaceutical BMRN stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock BMRN Biomarin Pharmaceutical These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BMRN Experts View which covers a lot of information including buying and selling signals
BMRN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Biomarin Pharmaceutical or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Biomarin Pharmaceutical (BMRN) Technical (Analysis) Reports Biomarin Pharmaceutical ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
